Unfortunately I didn't stay to the very end but MDVN was the stock that allowed me to retire early. I owe a big thank you to Ceo Hung who has been nothing less than great at making deals. Talazoparib was a recent acquisition that he stole for just $400 and is now the pearl in MDVN's pipeline. Kicking myself for getting out early and congrats to those who have stayed thru the rough waters. I remember the lone miss by Hung when Dimebon flopped. But Hung had strategically licensed Dimebon with PFE back then and he used the PFE money to carry on with Xtandi. I'd like to see what Hung wants to do next with the boatload of cash of cash PFE is giving him. I would be interested in investing with him again.